Modulation of tamoxifen-induced hepatotoxicity by tamoxifen-phospholipid complex

Journal of Pharmacy and Pharmacology

Volumn 67, Issue 9, 2015, Pages 1198-1206

  Jena, Sunil K ^a   Suresh, Sarasija ^a   Sangamwar, Abhay T ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

antioxidants; hepatotoxicity; reactive oxygen species; tamoxifen; tamoxifen phospholipid complex

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; PHOSPHOLIPID; SUPEROXIDE DISMUTASE; TAMOXIFEN; TAMOXIFEN DERIVATIVE; TAMOXIFEN PHOSPHOLIPID COMPLEX; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG; ANTIOXIDANT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; COMPLEX FORMATION; CONTROLLED STUDY; DRUG FORMULATION; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER PROTECTION; LIVER TOXICITY; NONHUMAN; RAT; SPRAGUE DAWLEY RAT; TREATMENT DURATION; ANIMAL; CHEMISTRY; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; LIVER; METABOLISM;

ALANINE TRANSAMINASE; ANIMALS; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; DRUG-INDUCED LIVER INJURY; FEMALE; LIPID PEROXIDATION; LIVER; PHOSPHOLIPIDS; RATS; RATS, SPRAGUE-DAWLEY; TAMOXIFEN;

EID: 84938750490     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12422     Document Type: Article

References (44)

1. Jordan VC,. Tamoxifen: a most unlikely pioneering medicine. Nat Rev Drug Discov 2003; 2: 205-213.
2. White INH,. The tamoxifen dilemma. Carcinogenesis 1999; 20: 1153-1160.
3. Caballero F, etal. On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice. Int J Biochem Cell Biol 2001; 33: 681-690.
4. Davies AM, etal. Peroxidase activation of 4-hydroxytamoxifen to free radicals detected by EPR spectroscopy. Free Radic Biol Med 1997; 22: 423-431.
5. Athoupa M, etal. Alterations of drug metabolizing and antioxidant enzyme activities during tamoxifen-induced hepatocarcinogenesis in rats. Carcinogenesis 1994; 15: 863-868.
6. Turner MJIII, etal. Evidence for superoxide formation during hepatic metabolism of tamoxifen. Biochem Pharmacol 1991; 41: 1701-1705.
7. Farrell GC,. Drugs and steatohepatitis. Semin Liver Dis 2002; 22: 185-194.
8. Elefsiniotis IS, etal. Tamoxifen induced hepatotoxicity in breast cancer patients with pre-existing liver steatosis: the role of glucose intolerance. Eur J Gastroenterol Hepatol 2004; 16: 593-598.
9. Nazarewicz RR, etal. Tamoxifen induces oxidative stress and mitochondrial apoptosis via stimulating mitochondrial nitric oxide synthase. Cancer Res 2007; 67: 1282-1290.
10. Küllenberg D, etal. Health effects of dietary phospholipids. Lipids Health Dis 2012; 11: 1-16.
11. Sampalis F, Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications. 2013; US 2013/0202689 A1.
12. Nwosu CV, etal. Effect of fatty acid composition of phospholipids on their antioxidant properties and activity index. J Am Oil Chem Soc 1997; 74: 293-297.
13. Tabassum H, etal. Attenuation of tamoxifen-induced hepatotoxicity by taurine in mice. Clin Chim Acta 2006; 370: 129-136.
14. El-Beshbishy HA,. Lipoic acid attenuates DNA fragmentation, oxidative stress and liver injury induced by tamoxifen in rats. Asian J Tradit Med 2007; 2: 175-188.
15. Al-Jassabi S, etal. Toxic effects of tamoxifen and the protective role of silymarin and zizyphus. Middle East J Sci Res 2011; 9: 110-114.
16. Ponthan F, etal. Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat. Br J Cancer 2014; 85: 2004-2009.
17. Maiti K, etal. Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 2007; 330: 155-163.
18. Maiti K, etal. Enhanced therapeutic benefit of quercetin-phospholipid complex in carbon tetrachloride-induced acute liver injury in rats: a comparative study. Iran J Pharmacol Ther 2005; 4: 84-90.
19. Bhattacharyya S, etal. The gallic acid-phospholipid complex improved the antioxidant potential of gallic acid by enhancing its bioavailability. AAPS PharmSciTech 2013; 14: 1025-1033.
20. Conti M, etal. Protective activity of silybin-phosphatidylcholine complex on liver damage in rodents. Jpn J Pharmacol 1992; 60: 315-321.
21. Buzzelli G, etal. A pilot study on the liver protective effect of silybin-phosphatidylcholine complex (IdB1016) in chronic active hepatitis. Int J Clin Pharmacol Ther Toxicol 1993; 31: 456-460.
22. Jena SK, etal. Development of tamoxifen-phospholipid complex: novel approach for improving solubility and bioavailability. Int J Pharm 2014; 473: 1-9.
23. Ellman GL,. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77.
24. Haque R, etal. Aqueous extract of walnut (Juglans regia L.) protects mice against cyclophosphamide-induced biochemical toxicity. Hum Exp Toxicol 2003; 22: 473-480.
25. Habig WH, etal. Glutathione-S-transferase: the first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-7139.
26. Kono Y,. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 1978; 186: 189-195.
27. Claiborne A,. Catalase activity. In:, Greenwald RA, ed. Handbook of Methods for Oxygen Radical Research. Boca Raton, Florida, USA: CRC Press, 1985: 283-284.
28. Wills ED,. Mechanisms of lipid peroxide formation in animal tissues. Biochem J 1966; 99: 667-676.
29. Han J, etal. Betanin attenuates paraquat-induced liver toxicity through a mitochondrial pathway. Food Chem Toxicol 2014; 70: 100-106.
30. Bacchetta C, etal. Biochemical stress responses in tissues of the cichlid fish Cichlasoma dimerus exposed to a commercial formulation of endosulfan. Arch Environ Contam Toxicol 2011; 61: 453-460.
31. 2-deoxyguanosinyl)tamoxifen N-oxide. Carcinogenesis 2000; 21: 1737-1744.
32. Albukhari AA, etal. Caffeic acid phenethyl ester protects against tamoxifen-induced hepatotoxicity in rats. Food Chem Toxicol 2009; 47: 1689-1695.
33. Podobed OV, etal. Hepatoprotective properties of phospholiv, a preparation containing phosphatidylcholine from sunflower seeds and glycyrrhizic acid, in modeled cirrhosis of rat liver. Bull Exp Biol Med 1997; 124: 311-314.
34. 4 damage. Vopr Med Khim 1995; 41: 13-16.
35. Seven A, etal. Effects of vitamin E supplementation on oxidative stress in streptozotocin induced diabetic rats: investigation of liver and plasma. Yonsei Med J 2004; 45: 703-710.
36. El-Beshbishy HA,. Hepatoprotective effect of green tea (Camellia sinensis) extract against tamoxifen-induced liver injury in rats. J Biochem Mol Biol 2005; 38: 563-570.
37. Lu SC,. Regulation of hepatic glutathione synthesis: current concepts and controversies. FASEB J 1999; 13: 1169-1183.
38. Lee YS,. Role of NAD(P)H oxidase in the tamoxifen-induced generation of reactive oxygen species and apoptosis in HepG2 human hepatoblastoma cells. Cell Death Differ 2000; 7: 925-932.
39. Kidd PM,. Phosphatidylcholine: a superior protectant against liver damage. Altern Med Rev 1996; 1: 258-274.
40. Das SK, Vasudevan DM,. Monitoring oxidative stress in patients with non-alcoholic and alcoholic liver diseases. Indian J Clin Biochem 2005; 20: 24-28.
41. Brito NJ, etal. Antioxidant activity and protective effect of Turnera ulmifolia Linn. var. elegans against carbon tetrachloride-induced oxidative damage in rats. Food Chem Toxicol 2012; 50: 4340-4347.
42. Kakkar R, etal. Antioxidant defense system in diabetic kidney. Life Sci 1997; 60: 667-679.
43. Gaetani GF, etal. Catalase and glutathione peroxidase are equally active in detoxification of hydrogen peroxide in human erythrocytes. Blood 1989; 73: 334-339.
44. Saito H, Ishihara K,. Antioxidant activity and active sites of phospholipids as antioxidants. J Am Oil Chem Soc 1997; 74: 1531-1536.